Stay updated on ABRAZO Clinical Trial
Sign up to get notified when there's something new on the ABRAZO Clinical Trial page.

Latest updates to the ABRAZO Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record is displayed, including study details, outcomes, eligibility criteria, locations, and data-sharing information, replacing a 403 error screen.SummaryDifference74%

- Check9 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA site-wide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1. The study record still shows a 403 Forbidden error.SummaryDifference0.3%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of study information.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now renders a 403 Forbidden error page with HTML boilerplate, indicating restricted access to the study record. This signals a site access issue rather than a modification to the trial information.SummaryDifference17%

Stay in the know with updates to ABRAZO Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABRAZO Clinical Trial page.